“雙重診斷雜志”是一份季刊，國際刊物，側(cè)重于雙重診斷的全部復(fù)雜性。精神健康和物質(zhì)使用障礙或“雙重診斷”的共同發(fā)生是行為健康的典型問題之一。為什么存在如此高的共現(xiàn)率？它告訴我們有關(guān)風(fēng)險概況的信息？這些相關(guān)疾病如何影響人們，他們的家庭以及他們所居住的社區(qū)？恢復(fù)的自然途徑是什么？哪些具體的治療方法最有幫助？如何開發(fā)新的治療方法？我們?nèi)绾卧谂R床，行政和政策層面加強(qiáng)循證實(shí)踐的實(shí)施？我們?nèi)绾螏椭蛻魧W(xué)習(xí)主動康復(fù)技能并采用所需的支持，臨床醫(yī)生掌握新的干預(yù)措施，實(shí)施有效服務(wù)的計劃以及促進(jìn)健康調(diào)整的社區(qū)？雙重診斷雜志包括來自與該領(lǐng)域相關(guān)的四個總體領(lǐng)域的文章和觀點(diǎn)：精神藥理學(xué)和神經(jīng)生物學(xué);心理治療與心理社會問題;服務(wù)與政策;和臨床論壇。每個問題都有助于鼓勵這些領(lǐng)域的整合。該雜志旨在發(fā)表與廣泛對雙重診斷感興趣的人相關(guān)的文章：研究人員，醫(yī)生，臨床醫(yī)生，受訓(xùn)人員，管理人員和政策制定者。高質(zhì)量的實(shí)證研究，簡要報告，及時評論，發(fā)人深思的評論以及對臨床問題的持續(xù)討論將被考慮出版，所有這些都旨在更好地理解共同基礎(chǔ)和最佳治療方法。發(fā)生精神和物質(zhì)使用障礙。

Journal of Dual Diagnosis is a quarterly, international publication that focuses on the full spectrum of complexities regarding dual diagnosis. The co-occurrence of mental health and substance use disorders, or “dual diagnosis,” is one of the quintessential issues in behavioral health. Why do such high rates of co-occurrence exist? What does it tell us about risk profiles? How do these linked disorders affect people, their families, and the communities in which they live? What are the natural paths to recovery? What specific treatments are most helpful and how can new ones be developed? How can we enhance the implementation of evidence-based practices at clinical, administrative, and policy levels? How can we help clients to learn active recovery skills and adopt needed supports, clinicians to master new interventions, programs to implement effective services, and communities to foster healthy adjustment?Journal of Dual Diagnosis includes articles and perspectives from four overarching domains relevant to the field: Psychopharmacology & Neurobiology; Psychotherapy & Psychosocial Issues; Services & Policy; and Clinical Forum. Each issue serves to encourage integration of these domains. The Journal seeks to publish articles relevant to a wide range of people interested in dual diagnosis: researchers, physicians, clinicians, trainees, administrators, and policy makers. High-quality empirical research, brief reports, timely reviews, thought-provoking commentaries, and ongoing discussions of clinical issues will be considered for publication, all with the aim of developing a better understanding of the basis of, and optimal treatment for, co-occurring psychiatric and substance use disorders.